instruction
stringclasses 1
value | input
stringlengths 6
305
| output
stringlengths 6
158
|
|---|---|---|
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | EGFR MUTATION POSITIVE NON-SMALL CELL LUNG CANCER | EGFR MUTATION POSITIVE NON-SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | SMALL CELL LUNG CANCER | SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | NON-SMALL CELL LUNG CANCER | NON-SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | KLIPPEL-TRINONAY SYNDROME | KLIPPEL-TRINONAY SYNDROME |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA | REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS | PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | LYMPHOMA | LYMPHOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | HYPOPHARYNGEAL CANCER | HYPOPHARYNGEAL CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA | LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | RECURRENT CERVICAL CANCER | RECURRENT CERVICAL CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | DUCHENNE MUSCULAR DYSTROPHY (DMD) | DUCHENNE MUSCULAR DYSTROPHY (DMD) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PI3KDELTA SYNDROME | PI3KDELTA SYNDROME |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | HER2-POSITIVE METASTATIC BREAST CANCER | HER2-POSITIVE METASTATIC BREAST CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | RECURRENT GLIOBLASTOMA (GLIOBLASTOMA IDH-WILDTYPE WHO GRADE 4) | RECURRENT GLIOBLASTOMA (GLIOBLASTOMA IDH-WILDTYPE WHO GRADE 4) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | OROPHARYNGEAL ORIGIN (HPV 16 POSITIVE), PRIMARY LESION UNKNOWN, CANCER | OROPHARYNGEAL ORIGIN (HPV 16 POSITIVE), PRIMARY LESION UNKNOWN, CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ACQUIRED IMMUNODEFICIENCY SYNDROME | ACQUIRED IMMUNODEFICIENCY SYNDROME |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | EGFR EXON 20 INSERTION NON-SMALL CELL LUNG CANCER | EGFR EXON 20 INSERTION NON-SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | METASTATIC CASTRATION-RESISTANT PROSTATE CANCER | METASTATIC CASTRATION-RESISTANT PROSTATE CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | RECURRENT ANAPLASTIC PLEOMORPHIC ASTROCYTOMA | RECURRENT ANAPLASTIC PLEOMORPHIC ASTROCYTOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PYRUVATE KINASE DEFICIENCY | PYRUVATE KINASE DEFICIENCY |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | DIFFUSE LARGE B-CELL LYMPHOMA | DIFFUSE LARGE B-CELL LYMPHOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PAPILLARY THYROID CANCER | PAPILLARY THYROID CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ADVANCED RENAL CELL CARCINOMA | ADVANCED RENAL CELL CARCINOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | UNRESECTABLE LOCALLY RECURRENT SQUAMOUS/NON-SQUAMOUS CELL HEAD AND NECK CANCER | Locally Recurrent Squamous Cell Head and Neck Cancer, Locally Recurrent Non-Squamous Cell Head and Neck Cancer |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | INCREASED ESSENTIAL PLATELETS | INCREASED ESSENTIAL PLATELETS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | GLIOBLASTOMA (WHO GRADE 4) | GLIOBLASTOMA (WHO GRADE 4) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | AMYOTROPHIC LATERAL SCLEROSIS (ALS) | AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | HER2 BENIGN METASTATIC BREAST | HER2 BENIGN METASTATIC BREAST |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | GASTROINTESTINAL STROMAL TUMOR | GASTROINTESTINAL STROMAL TUMOR |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | AMYOTROPHIC LATERAL SCLEROSIS | AMYOTROPHIC LATERAL SCLEROSIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | REFRACTORY ACUTE MYELOID LEUKEMIA | REFRACTORY ACUTE MYELOID LEUKEMIA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PATIENTS WITH HISTOLOGICALLY CONFIRMED EPITHELIAL OVARIAN CANCER, PRIMARY PERITONEAL CARCINOMA, OR FALLOPIAN TUBE CANCER JUDGED TO BE IN THE TERMINAL STAGE; PATIENTS WHO CAN RECEIVE CHEMOTHERAPY BUT DO NOT HAVE CYTOTOXIC ANTICANCER DRUGS OR TARGETED TREATMENTS THAT CAN BE ADMINISTERED FROM APPROVED DRUGS | Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) WITH LEPTOMENINGEAL METASTASIS | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) WITH LEPTOMENINGEAL METASTASIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | UNRESECTABLE ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) | UNRESECTABLE ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | CHOLANGIOCARCINOMA OF THE INTRAHEPATIC BILE DUCT | CHOLANGIOCARCINOMA OF THE INTRAHEPATIC BILE DUCT |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | BRAFV600 MUTATION-POSITIVE UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA | BRAFV600 MUTATION-POSITIVE UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS | FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | DIFFUSE PEDIATRIC-TYPE HIGH GRADE GLIOMA, H3-WILDTYPE AND IDH-WILDTYPE GRADE 4, RECURRENCE | DIFFUSE PEDIATRIC-TYPE HIGH GRADE GLIOMA, H3-WILDTYPE AND IDH-WILDTYPE GRADE 4, RECURRENCE |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | STAGE 4 BREAST CANCER WITH MULTIPLE METASTASES | STAGE 4 BREAST CANCER WITH MULTIPLE METASTASES |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | MALIGNANT SUBMANDIBULAR GLAND TUMOR | MALIGNANT SUBMANDIBULAR GLAND TUMOR |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | GALLBLADDER CANCER WITH METASTASIS | GALLBLADDER CANCER WITH METASTASIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | GENERALIZED MYASTHENIA GRAVIS | GENERALIZED MYASTHENIA GRAVIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | NON-SMALL CELL LUNG CANCER WITH FGFR GENE MUTATION | NON-SMALL CELL LUNG CANCER WITH FGFR GENE MUTATION |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) | SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | RELAPSED OR REFRACTORY MULTIPLE MYELOMA WITH FOUR OR MORE PRIOR TREATMENTS INCLUDING ANTI-CD38 ANTIBODIES, PROTEASOME INHIBITORS, AND IMMUNOMODULATORS | Multiple Myeloma, Anti-CD38 Antibodies, Proteasome Inhibitors, Immunomodulators |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PSMA-POSITIVE METASTATIC PROSTATE CANCER OR ADENOCYSTIC CARCINOMA | PSMA-POSITIVE METASTATIC PROSTATE CANCER OR ADENOCYSTIC CARCINOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | STEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE | STEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | KRAS G12C MUTATION NON-SMALL CELL LUNG CANCER | KRAS G12C MUTATION NON-SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | RECURRENT PROGRESSIVE ENDOMETRIAL CANCER | RECURRENT PROGRESSIVE ENDOMETRIAL CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | MILD COGNITIVE IMPAIRMENT (MCI) AND MILD ALZHEIMER'S DISEASE (AD) DUE TO ALZHEIMER'S DISEASE (AD) | Mild Cognitive Impairment, Alzheimer's Disease |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | MET AMPLIFICATION NON-SMALL CELL LUNG CANCER | MET AMPLIFICATION NON-SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | NON-MOTOR SYMPTOMS (NMS) IN PATIENTS WITH ADVANCED PARKINSON DISEASE | NON-MOTOR SYMPTOMS (NMS) IN PATIENTS WITH ADVANCED PARKINSON DISEASE |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PATIENTS WITH SEVERE PNEUMONIA INFECTED WITH COVID-19 [# COVID-19] | Severe Pneumonia Infected with COVID-19 |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WITH PREVIOUSLY TREATED EGFR EXON 20 INSERTION GENE MUTATION | Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Gene Mutation |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | KRAS G12C MUTATION LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER | Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | CHRONIC GRAFT-VERSUS-HOST RESPONSE | CHRONIC GRAFT-VERSUS-HOST RESPONSE |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | STEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST REACTION | STEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST REACTION |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | CANCER OF UNKNOWN ORIGIN (MUO: METASTASIS OF UNKNOWN ORIGIN) | CANCER OF UNKNOWN ORIGIN (MUO: METASTASIS OF UNKNOWN ORIGIN) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | MAXILLARY SINUS CANCER (PICK3A MUTATION) | MAXILLARY SINUS CANCER (PICK3A MUTATION) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PATIENTS WITH PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-POSITIVE TUMORS (PROSTATE CANCER, ADENOID CYSTIC CANCER, HEPATOCELLULAR CARCINOMA, ETC.) | Prostate Cancer, Adenoid Cystic Cancer, Hepatocellular Carcinoma |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | CORTICOSTEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (SR-CGVHD) | CORTICOSTEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (SR-CGVHD) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | FLT GENE MUTATION POSITIVE RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA | FLT GENE MUTATION POSITIVE RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | SEVERE PNEUMONIA CAUSED BY COVID-19 (ARDS) [# COVID-19] | SEVERE PNEUMONIA CAUSED BY COVID-19 (ARDS) [# COVID-19] |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) | NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | PLEOMORPHIC XANTHOSTROCYTOMA (GLIOMA) | PLEOMORPHIC XANTHOSTROCYTOMA (GLIOMA) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | TONGUE CANCER | TONGUE CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ESSENTIAL THROMBOCYTOSIS | ESSENTIAL THROMBOCYTOSIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | LOW GRADE GLIOMA | LOW GRADE GLIOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | UTERINE CANCER (CARCINOSARCOMA) | UTERINE CANCER (CARCINOSARCOMA) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | LONG-CHAIN FATTY ACID OXIDATION DISORDER | LONG-CHAIN FATTY ACID OXIDATION DISORDER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ADVANCED SOLID TUMORS WITH SPECIFIC KRAS MUTATIONS, ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) | ADVANCED SOLID TUMORS WITH SPECIFIC KRAS MUTATIONS, ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | METASTATIC COLORECTAL CANCER | METASTATIC COLORECTAL CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | SOLID CANCER WITH UNSPECIFIED PRIMARY SITE | SOLID CANCER WITH UNSPECIFIED PRIMARY SITE |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | CORTICOSTEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (SR-CGVHD) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION | CORTICOSTEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (SR-CGVHD) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | SKIN CANCER WITH HRAS MUTATIONS | SKIN CANCER WITH HRAS MUTATIONS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | METASTATIC PANCREATIC CANCER | METASTATIC PANCREATIC CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ADVANCED ROS1 POSITIVE NON-SMALL CELL LUNG CANCER | ADVANCED ROS1 POSITIVE NON-SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | NON-SMALL CELL LUNG CANCER, ROS-1 GENETIC MUTATION | NON-SMALL CELL LUNG CANCER, ROS-1 GENETIC MUTATION |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | RENAL EPITHELIOID ANGIOMYOLIPOMA | RENAL EPITHELIOID ANGIOMYOLIPOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ALK-POSITIVE GLIOBLASTOMA | ALK-POSITIVE GLIOBLASTOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | MEDULLARY THYROID CANCER | MEDULLARY THYROID CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | MODERATE TO SEVERE PLAQUE PSORIASIS | MODERATE TO SEVERE PLAQUE PSORIASIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER | ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | EPSTEIN-BARR VIRUS (EBV) ASSOCIATED LYMPHOEPITHELIOD CARCINOMA | EPSTEIN-BARR VIRUS (EBV) ASSOCIATED LYMPHOEPITHELIOD CARCINOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | COVID-19 INFECTION [# COVID-19] | COVID-19 INFECTION [# COVID-19] |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | CERVICAL ADENOCARCINOMA | CERVICAL ADENOCARCINOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ADRENOCORTICAL CARCINOMA | ADRENOCORTICAL CARCINOMA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | RET FUSION-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER, RET MUTATION-POSITIVE MEDULLARY THYROID CANCER, OR RET FUSION-POSITIVE THYROID CANCER | RET FUSION-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER, RET MUTATION-POSITIVE MEDULLARY THYROID CANCER, OR RET FUSION-POSITIVE THYROID CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE | REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | WALDENSTROM MACROGLOBULINEMIA | WALDENSTROM MACROGLOBULINEMIA |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | SENSITOID ANAPLASTIC CARCINOMA WITH NTRK FUSION MUTATION | SENSITOID ANAPLASTIC CARCINOMA WITH NTRK FUSION MUTATION |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ATOPIC DERMATITIS | ATOPIC DERMATITIS |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | COMMON BILE DUCT CANCER | COMMON BILE DUCT CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | THYROID ANAPLASTIC CARCINOMA WITH NTRK FUSION MUTATION | THYROID ANAPLASTIC CARCINOMA WITH NTRK FUSION MUTATION |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ADVANCED ALK MUTANT NON-SMALL CELL LUNG CANCER | ADVANCED ALK MUTANT NON-SMALL CELL LUNG CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ORAL CANCER | ORAL CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | SOFT TISSUE SARCOMA (PERIPHERAL NERVE SHEATH MALIGNANCY) | SOFT TISSUE SARCOMA (PERIPHERAL NERVE SHEATH MALIGNANCY) |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ENDOMETRIAL CANCER | ENDOMETRIAL CANCER |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | ATOPIC DERMATITIS OF UNKNOWN ORIGIN | ATOPIC DERMATITIS OF UNKNOWN ORIGIN |
Extract the therapeutic area from the given input and use a comma separator in cases where multiple therapeutic areas are present. | BRAF V600E MUTATION-POSITIVE ANAPLASTIC THYROID CANCER | BRAF V600E MUTATION-POSITIVE ANAPLASTIC THYROID CANCER |
End of preview. Expand
in Dataset Viewer.
No dataset card yet
New: Create and edit this dataset card directly on the website!
Contribute a Dataset Card- Downloads last month
- 4